At SupplySide Global, Gelita’s Angie Rimel explains how collagen proteins can help brands build nutrient-dense products that earn repeat purchases.

Live from SupplySide Global 2026, Nutritional Outlook’s Nicholas Jacobus speaks with Denis Neville, founder and CEO of CoreFX Ingredients, about the launch of CreaSHLD-IN.

At SupplySide Global, Kriti Chaudhary explains how nutraceutical brands can turn clinical research into a price premium and a claim that holds up.

Live from SupplySide Global 2026, Nutritional Outlook’s Nicholas Jacobus speaks with Brian Appell, product manager, Givaudan, about the launch of NovaBerin for the metabolic health market.

Researchers analyzing FDA adverse-event data report higher cardiac event reporting for caffeine and stimulant products, while the Council for Responsible Nutrition says the design cannot show risk.

Live from SupplySide Global 2026, Nutritional Outlook’s Nicholas Jacobus speaks with Elzaphan Hotam, director at TriNutra, about new clinical and preprint data on ThymoQuin.

At SupplySide Global, Dominik Mattern discussed Balchem’s Optifolin+, methylation and DNA health, formulation challenges, and Vital Choline’s cognitive-health research amid growing interest in longevity and healthy aging.

Live from SupplySide Global 2026, Nutritional Outlook’s Nicholas Jacobus speaks with Komal Baldwa, founder and CEO of aspurus about the company’s life-stage optimized dosing platform for women’s health.